Fri Feb 25, 2022 – 2:53 pm EST
STOCKHOLM, Sweden (LifeSiteNews) – Sweden formally recommended against puberty blockers and other transgender hormone drugs for children this week in a move hailed by experts as a “major departure” from dangerous existing standards.
In new guidelines released Tuesday, the Swedish National Board of Health and Welfare (NBHW) said that it now “recommends restraint” regarding hormone drugs, citing “uncertain science” and significant side-effect risks.
Transgender hormones should be strictly prohibited for minors who develop gender dysphoria after the beginning of puberty, the NBHW said Tuesday in a press release, and otherwise should only be used in research settings or “exceptional cases.” Gender dysphoria is a mental illness due to a disordered, so-called “gender identity” at odds with one’s biological sex.
Sweden will also centralize gender clinics to a handful of national centers and ban experimental “gender-affirming” practices at private clinics, the NBHW said.
“Increased knowledge is needed, among other things, about the effects of the treatments on gender dysphoria and the mental health and quality of life of minors, in both the short and long term,” the NBHW’s Dr. Thomas Lindén said. The risks of hormone drugs for those
The remainder of this article is available in its entirety at LifeSite News
The views expressed in this news alert by the author do not directly represent that of The Official Street Preachers or its editors
